Topical ofloxacin for chronic suppurative otitis media and acute exacerbation of chronic otitis media: Optimum duration of treatment

Otology and Neurotology

Volumn 24, Issue 3, 2003, Pages 447-452

  Suzuki, Kenji ^a,b   Nishimura, Tadao ^a   Baba, Shunkichi ^b   Yanagita, Noriyuki ^c   Ishigami, Hiromichi ^d  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic suppurative otitis media; Topical Ofloxacin

Indexed keywords

OFLOXACIN; TARIVID OTIC SOLUTION;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECZEMA; ERADICATION THERAPY; FEMALE; FOLLOW UP; HEADACHE; HEARING IMPAIRMENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR EFFUSION; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; OTALGIA; OTITIS MEDIA; PRIORITY JOURNAL; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; SUPPURATIVE OTITIS MEDIA; TINNITUS; TONSILLITIS; TREATMENT OUTCOME; VERTIGO;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OTITIS MEDIA, SUPPURATIVE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0038137042     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200305000-00015     Document Type: Article

References (22)

1. Sato K, Ogawa A, Miyazaki T, et al. Experimental and pathohistologic study of the influence of cefmenoxime topical otic solution on the cochlear organ [in Japanese]. Otologia Fukuoka 1984;30:157-66.
2. Baba S, Kobayashi T, Saito S, et al. Double-blind clinical trial of cefmenoxime (CMX) otic solution for the treatment of chronic purulent otitis media and its acute exacerbations [in Japanese]. Otologia Fukuoka 1985;31:525-68.
3. Kurebe M, Yokota M, Sakamoto K, et al. Effect of fosfomycin on auditory organs and its transfer to cochlear lymph following application of a solution to the middle ear cavity [in Japanese]. Jpn J Antibiot 1985;38:3481-86.
4. Baba S, Shimada J, Maruo T, et al. A double-blind clinical study of fosfomycin (FOM) otic solution for the treatment of chronic suppurative otitis media and its acute exacerbations [in Japanese]. Otologia Fukuoka 1986;32:868-923.
5. Nobori T, Hanamure Y, Matuzaki T, et al. Influence of ofloxacin on the cochlea after topical administration into the middle ear cavity [in Japanese]. Otologia Fukuoka 1988;34:1028-34.
6. Sato K, Miyazaki T, Araki N, et al. Experimental study of the influence of ofloxacin (OFLX) otic solution on the inner ear [in Japanese]. Otologia Fukuoka 1989;35:58-64.
7. Barlow DW, Duckert LG, Kreig CS, et al. Ototoxicity of topical otomicrobial agents. Acta Otolaryngol 1994;115:231-5.
8. Kato M, Akahane K, Shimoda K. Lack of chondrotoxicity of ofloxacin otic solution on the auditory ossicle cartilages of juvenile guinea pigs. J Antimicrob Chemother 1997;39:269-71.
9. Sato K, Nukuzuma S, Samejima S. Experimental study of the influence of NY-198 topical otic solution on the cochlear organ [in Japanese]. J Jpn Soc Infect Dis Otolaryngol 1988;6:94-8.
10. Baba S, Kobayashi T, Kawamura S, et al. Phase III study of lomefloxacin (NY-198) otic solution for the treatment of chronic purulent otitis media and its acute exacerbations [in Japanese]. Otologia Fukuoka 1991;37:78-108.
11. Deguchi K, Yokota N, Koguchi M, et al. Bacteriological evaluation of ofloxacin otic solution [in Japanese]. Jpn J Antibiot 1992;45:1342-55.
12. Kawamura S, Ichikawa G, Uehara N, et al. An early phase II study of ofloxacin solution in suppurative otitis media [in Japanese]. Otologia Fukuoka 1990;36:523-36.
13. Baba S, Kobayashi T, Takasaka T, et al. Comparative dose-finding study of ofloxacin otic solution in suppurative otitis media [in Japanese]. Otologia Fukuoka 1990;36:537-63.
14. Baba S, Kobayashi T, Saito S, et al. Double-blind clinical trial of ofloxacin otic solution for the treatment of chronic suppurative otitis media and its acute exacerbations [in Japanese]. Otologia Fukuoka 1990;36:564-89.
15. Baba S, Kobayashi T, Shimada J, et al. A clinical study of ofloxacin otic solution for purulent otitis media and otitis externa in children [in Japanese]. Otologia Fukuoka 1990;36:590-604.
16. Supiyaphun P, Tonsakulrungruang K, Chochaipanichnon L, et al. The treatment of chronic suppurative otitis media and otitis externa with 0.3% ofloxacin otic solution: a clinico-microbiologic study. Med Assoc Thai 1995;78:18-21.
17. Tong MCF, Woo JKS, van Hasselt CA. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin Bhydrocortisone otic drops in the medical treatment of chronic suppurative otitis media. J Laryngol Otol 1996;110:309-14.
18. Jones RN, Milazzo J, Seidlin M. Ofloxacin otic solution for treatment of otitis externa in children and adults. Arch Otolaryngol Head Neck Surg 1997;123:1193-200.
19. Kato M, Onodera T. Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats. Fundamental Appl Toxicol 1988;11:110-9.
20. Suzuki K, Baba S. Antimicrobial ear drop medication therapy. Acta Otolaryngol 1996;(Suppl 525):68-72.
21. Dohar JE, Garner ET, Biel MA, Seidlin M. Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes. Arch Otolaryngol Head Neck Surg 1999;125:537-45.
22. Simpson KL, Markham A. Ofloxacin otic solution: a review of its use in the management of ear infections. Drugs 1999;58:509-31.